Jing Lin, Yuping Lu, Huishan Zhang, Ping Chen, Dingyi Wang, Yu Chen. "Tofacitinib for immune-related adverse events ≥ grade 3 induced by immune checkpoint inhibitors: A single-arm, open-label, two-stage study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.81